Biological Markers of Exposure to Chemical Warfare Agents

Chemical Warfare Agents: Toxicology and Treatment, Second Edition

Volumn , Issue , 2007, Pages 127-156

  Black, Robin M ^a   Noort, Daan ^b  

^a DEFENCE SCIENCE AND TECHNOLOGY LABORATORY   (United Kingdom)

^b TNO   (Netherlands)

Author keywords

CW agents and biological markers of exposure; Highly reactive phosgene electrophile; Nerve agents sarin (GB), VX and tabun (GA) Soman (GD) and cyclosarin (GF); Riot control agents (RCAs) contravening CWC; Sulphur and nitrogen mustards

Indexed keywords

EID: 84890246664     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470060032.ch5     Document Type: Chapter

References (123)

1. Adams TK, Capacio BR, Smith JR et al. (2004). The application of the fluoride reactivation process to the detection of sarin and soman nerve agent exposures in biological samples. Drug Chem Toxicol, 27, 77-91.
2. Bakke J and Gustafsson J-Å. (1984). Mercapturic acid pathway metabolites of xenobiotics: generation of potentially toxic metabolites during entereohepatic circulation. TIPS, 5, 517-521.
3. Barr JR, Driskell WJ, Aston LS. (2004). Quantitation of metabolites of the nerve agents sarin, soman, cyclosarin, VX and Russian VX in human urine using isotope-dilution gas chromatographytandem mass spectrometry. J Anal Toxicol, 28, 372-378.
4. Bartlett PD and Swain CG. (1949). Kinetics of hydrolysis and displacement reactions of β, β'-dichlorodiethyl sulfide (mustard gas) and of β-chloro-β'-hydroxydiethyl sulfide (mustard chlorohydrin). J Am Chem Soc, 71, 1406-1415.
5. Benschop HP, Van der Schans GP, Noort D et al. (1997). Verification of exposure to sulfur mustard in two casualties of the Iran-Iraq conflict. J Anal Toxicol, 21, 249-251.
6. Benschop HP, Noort D, Van der Schans GP et al. (2000). Diagnosis and dosimetry of exposure to sulfur mustard: development of standard operating procedures; further exploratory research on protein adducts. Final Report Cooperative Agreement DAMD17-97-2-7002, NTIS number: ADA381035/XAB. Springfield, VA, USA: NTIS.
7. Benschop HP and De Jong LPA (2001).Toxicokinetics of nerve agents. In: ChemicalWarfare Agents: Toxicity at Low Levels (SM Somani and JA Romano, eds), pp. 25-81. Boca Raton, FL, USA: CRC Press.
8. Black RM and Read RW. (1988). Detection of trace levels of thiodiglycol in blood, plasma and urine using gas chromatography-electron capture negative ion chemical ionisation mass spectrometry. J Chromatogr, 449, 261-270.
9. Black, RM and Read, RW (1991) Methods for the analysis of thiodiglycol sulphoxide, a metabolite of sulphur mustard, in urine using gas chromatography-mass spectrometry. J Chromatogr, 558, 393-404.
10. Black RM, Clarke RJ and Read RW. (1991). Analysis of 1, 1'-sulphonylbis[2-(methylsulphinyl)ethane] and 1-methylsulphinyl-2-[2-(methylthio)ethylsulphonyl]ethane, metabolites of sulphur mustard, in urine using gas chromatography-mass spectrometry. J Chromatogr, 558, 405-414.
11. Black RM, Brewster K, Clarke RJ et al. (1992a). Biological fate of sulphur mustard, 1, 1-thiobis (2-chloroethane): isolation and identification of urinary metabolites following intraperitoneal administration to rat. Xenobiotica, 22, 405-418.
12. Black RM, Hambrook JL, Howells DJ et al. (1992b). Biological fate of sulfur mustard, 1, 1'-thiobis (2-chloroethane). Urinary excretion profiles of hydrolysis products and β-lyase metabolites of sulfur mustard after cutaneous application in rats. J Anal Toxicol, 16, 79-84.
13. Black RM, Brewster K, Clarke RJ et al. (1993). Metabolism of thiodiglycol (2, 2'-thiobis-ethanol): isolation and identification of urinary metabolites following intraperitoneal administration to rat. Xenobiotica, 23, 473-481.
14. Black RM and Read RW (1995a). Improved methodology for the detection and quantitation of urinary metabolites of sulphur mustard using gas chromatography-tandem mass spectrometry. J Chromatogr B, 665, 97-105.
15. Black RM and Read RW (1995b). Biological fate of sulphur mustard, 1, 1-thiobis (2-chloroethane): identification of β-lyase metabolites and hydrolysis products in human urine. Xenobiotica, 25, 167-173.
16. Black RM, Clarke RJ, Harrison JM et al. (1997a). Biological fate of sulphur mustard: identification of valine and histidine adducts in haemoglobin from casualties of sulphur mustard poisoning. Xenobiotica, 27, 499-512.
17. Black RM, Harrison JM and Read RW (1997b). Biological fate of sulphur mustard: in vitro alkylation of human haemoglobin by sulphur mustard. Xenobiotica, 27, 11-32.
18. Black RM, Harrison JM and Read RW. (1999). The interaction of sarin and soman with plasma proteins: the identification of a novel phosphylation site. Arch Toxicol, 73, 123-126.
19. Black RM and Muir R (2003). Derivatization reactions in the chromatographic analysis of chemical warfare agents and their degradation products. J Chromatogr A, 1000, 253-281.
20. Black RM and Noort D (2005). Methods for the retrospective detection of exposure to toxic scheduled chemicals. Part A: analysis of free metabolites. In: Chemical Weapons Convention Related Analysis (M Mesilaakso, ed.), pp. 403-431. Chichester, UK: John Wiley & Sons Ltd.
21. Boyer AE, Ash D, BarrDet al. (2004). Quantitation of the sulfur mustard metabolites 1, 1'-sulfonylbis[2-(methylthio)ethane] and thiodiglycol in urine using isotope-dilution gas chromatography-tandem mass spectrometry. J Anal Toxicol, 28, 327-332.
22. Brewster K, Harrison JM, Leadbeater J et al. (1987). The fate of 2-chlorobenzylidene malononitrile (CS) in rats. Xenobiotica, 17, 911-924.
23. Brookes P and Lawley PD. (1960). The reaction of mustard gas with nucleic acids in vitro and in vivo. Biochem J, 77, 478-484.
24. Byrd GD, Sniegoski LT and White VE (1987). Development of a confirmatory chemical test for exposure to 3-quinuclidinyl benzilate (BZ). Report 1987 Order No. AD-A191746. US Army Medical Research & Development Command, Fort Dietrick, Maryland (Chem Abstr, 110, 70602).
25. Byrd GD, Sniegoski LT and White VE. (1988). Determination of 3-quinuclidinyl benzilate in urine. J Res Nat Bur Stand (US), 93, 293-295.
26. Capacio BR, Smith JR, DeLion MT et al. (2004). Monitoring of sulfur mustard exposure by gas chromatography-mass spectrometry: analysis of thiodiglycol cleaved from blood proteins. J Anal Toxicol, 28, 306-311.
27. Cucinell SA, Swentzel KC, Biskup R et al. (1971). Biochemical interactions and metabolic fate of riot control agents. Fed Proc, 30, 86-91.
28. Davison C, Rozman RS and Smith PK. (1961). Metabolism of bis-β-chloroethyl sulfide (sulfur mustard gas). Biochem Pharmacol, 7, 65-74.
29. Degenhardt CEAM, Pleijsier K, Van der Schans MJ et al. (2004). Improvements of the fluoride reactivation method for the verification of nerve agent exposure. J Anal Toxicol, 28, 364-371.
30. Diaz Gomez MI and Castro JA. (1980). Covalent binding of chloroform metabolites to nuclear proteins-no evidence for binding to nucleic acids. Cancer Lett, 9, 213-218.
31. Di Consiglio E, De Angelis G, Testai E et al. (2001). Correlation of a specific mitochondrial phospholipid-phosgene adduct with chloroform acute toxicity. Toxicology, 159, 43-53.
32. Drasch G, Kretschmer E, Kauert G et al. (1987). Concentrations of mustard gas [bis (2-chloroethyl)sulfide] in the tissues of a victim of vesicant exposure. J Forensic Sci, 32, 1788-1793.
33. Dunn MA, Brennie EH and Sidell FR (1997). Pretreatment for nerve agent exposure. In: Medical Aspects of Chemical and BiologicalWarfare (FR Sidell, ET Takafuji and DR Franz, eds), pp. 181-196. Washington, DC, USA: Office of the Surgeon General at TMM Publications, Borden Institute, Walter Read Army Medical Center.
34. Elhanany E, Ordentlich A, Dgany O et al. (2001). Resolving pathways of interaction of covalent inhibitors with the active site of acetylcholinesterases: MALDI-TOF/MS analysis of various nerve agent phosphyl adducts. Chem Res Toxicol, 14, 912-918.
35. Ellman GL, Courtney KD and Anders V. (1961). A newand rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol, 7, 88-95.
36. Fabrizi L, Taylor GW, Edwards RJ et al. (2001). Adducts of the chloroform metabolite phosgene. In: Biological Reactive Intermediates VI (Dansette PM, Snyder R, Delaforge M, eds), pp. 129-132. New York, NY, USA and Amsterdam, The Netherlands: Kluwer Academic/Plenum Publishers.
37. Fabrizi L, Taylor GW, Cañas B et al. (2003). Adduction of the chloroform metabolite phosgene to lysine residues of human histone H2B. Chem Res Toxicol, 16, 266-275.
38. Fidder A, Moes GWH, Scheffer AG et al. (1994). Synthesis, characterization and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood. Chem Res Toxicol, 7, 199-204.
39. Fidder A, Noort D, de Jong LPA et al. (1996). N7-(2-Hydroxyethylthioethyl)-guanine: a novel urinary metabolite following exposure to sulphur mustard. Arch Toxicol, 70, 854-855.
40. Fidder A, Noort D, Hulst AG et al. (2000). Biomonitoring of exposure to lewisite based on adducts to haemoglobin. Arch Toxicol, 74, 207-214.
41. Fidder A, Noort D, Hulst AG et al. (2002). Retrospective detection of exposure to organophosphorus anti-cholinesterases: mass spectrometric analysis of phosphylated human butyrylcholinesterase. Chem Res Toxicol, 15, 582-590.
42. Fredriksson S-Å, Hammarström L.-G, Henriksson L et al. (1995). Trace determination of alkyl methylphosphonic acids in environmental and biological samples using gas chromatography/negative-ion chemical ionization mass spectrometry and tandem mass spectrometry. J Mass Spectrom, 30, 1133-1143.
43. French MC, Harrison JM, Inch TD et al. (1983a). The fate of dibenz[b, f ]-1, 4-oxazepine (CR) in the rat, rhesus monkey and guinea-pig. Part I. Metabolism in vivo. Xenobiotica, 13, 345-359.
44. French MC, Harrison JM, Newman J. et al. (1983b). The fate of dibenz[b, f ]-1, 4-oxazepine (CR) in the rat. Part III. The intermediary metabolites. Xenobiotica, 13, 373-381.
45. Fung LW-M, Ho C, Roth EF et al. (1975). The alkylation of hemoglobin S by nitrogen mustard. J Biol Chem, 250, 4786-4789.
46. 35S-labelled sulphur mustard. Xenobiotica, 22, 65-75.
47. Hambrook JL, Howells DJ and Schock C. (1993). Biological fate of sulphur mustard (1, 1'-thiobis (2-chloroethane)): uptake, distribution and retention of 35S in skin and in blood after cutaneous application of 35S-sulphur mustard in rat and comparison with human blood in vitro. Xenobiotica, 23, 537-561.
48. Harrison JM, Clarke RJ, Inch TD et al. (1978). The metabolism of dibenz[b, f]-1, 4-oxazepine (CR): in vivo hydroxylation of 10, 11-dihydrodibenz[b, f]-1, 4-oxazepin-11-(1OH)-one and the NIH shift. Experientia, 34, 698-699.
49. Harrison JM, Read RW, Williams NH et al. (2007). Phosphylated tyrosine as a biomarker of exposure to organophosphorus nerve agents. Arch Toxicol, in press.
50. Ishii A, Seno H, Watanabe-Suzuki K, et al. (1998). Determination of cyanide in whole blood by capillary gas chromatography with cryogenic oven trapping. Anal Chem, 70, 4873-4876.
51. Jakubowski EM, Woodard CL, Mershon MM et al. (1990). Quantification of thiodiglycol in urine by electron ionization gas chromatography-mass spectrometry. J Chromatogr, 528, 184-190.
52. Jakubowski EM, Smith JR, Logan TP et al. (1993). Verification of lewisite exposure: quantification of chlorovinyl arsonous acid in biological samples. In: Proceedings of the 1993 Medical Defense Bioscience Review, 10-13 May, pp. 361-368. Aberdeen Proving Ground, MD, USA:USArmy Medical Research Institute of Chemical Defense.
53. Jakubowski EM, Sidell FR, Evans RA et al. (2000). Quantification of thiodiglycol in human urine after an accidental sulfur mustard exposure. Toxicol Methods, 10, 143-150.
54. Jakubowski EM, McGuire JM, Evans RA et al. (2004). Quantitation of fluoride ion released sarin in red blood cell samples by gas chromatography-chemical ionization mass spectrometry using isotope dilution and large-volume injection. J Anal Toxicol, 28, 357-363.
55. Kawada T and Iwai K. (1985). In vivo and in vitro metabolism of dihydrocapsaicin, a pungent principle of hot pepper, in rats. Agric Biol Chem, 49, 441-448.
56. Kubic VL and Anders MW (1980). Metabolism of carbon tetrachloride to phosgene. Life Sci, 26, 2151-2156.
57. Leadbeater L. (1973). The absorption of ochlorobenzylidene malononitrile (CS) by the respiratory tract. Toxicol Appl Pharmacol, 25, 101-110.
58. Lemire SW, Ashley DL and Calafat AM. (2003). Quantitative determination of the hydrolysis products of nitrogen mustards in human urine by liquid chromatography-electrospray ionization tandem mass spectrometry. J Anal Toxicol, 27, 1-6.
59. Lemire SW, Barr JR, Ashley DL et al. (2004). Quantitation of biomarkers of exposure to nitrogen mustards in urine from rats dosed with nitrogen mustards and from an unexposed human population. J Anal Toxicol, 28, 320-326.
60. Leung H-W, Ballantyne B and Frantgz SW. (1996). Pharmacokinetics of N-methyldiethanolamine following acute cutaneous and intravenous dosing in the rat. J Toxicol-Cutaneous Ocular Toxicol, 15, 343-353.
61. Logan TP, Smith JR, Jakubowski EM et al. (1999). Verification of lewisite exposure by the analysis of 2-chlorovinyl arsonous acid in urine. Toxicol Methods, 9, 275-284.
62. Logue BA, Kirschten NP, Petrikovics I et al. (2005). Determination of the cyanide metabolite 2-aminothiazoline-4-carboxylic acid in urine and plasma by gas chromatography-mass spectrometry. J Chromatogr B, 819, 237-244.
63. Ludlum DB, Austin-Ritchie P, Hagopian M et al. (1994). Detection of sulfur mustard-induced DNA modifications. Chem-Biol Interact, 91, 39-49.
64. Lundquist P, Kagedal B, Nilsson L et al. (1995). Analysis of the cyanide metabolite 2-aminothiazoline-4-carboxylic acid in urine by high-performance liquid chromatography. Anal Biochem, 228, 27-34.
65. Mackworth JR. (1948). The inhibition of thiol enzymes by lachrymators. Biochem J, 42, 82-90.
66. Maisonneuve A, Callebat I, Debordes L et al. (1993). Biological fate of sulphur mustard in rat: toxicokinetics and disposition. Xenobiotica, 23, 771-180.
67. Matsuda Y, Nagao M, Takatori T et al. (1998). Detection of sarin hydrolysis product in formalin-fixed brain tissues of victims of the Tokyo subway terrorist attack. Toxicol Appl Pharmacol, 150, 310-320.
68. Meng ZH and Qin L. (2001). Determination of degradation products of nerve agents in human serum by solid phase extraction using molecularly imprinted polymer. Anal Chim Acta, 435, 121-127.
69. Miki A, Katagi M, Tsuchihashi H et al. (1999). Determination of alkyl methylphosphonic acids, the main metabolites of organophosphorus nerve agents, in biofluids by gas chromatography-mass spectrometry by liquid-liquid-solid-phasetransfer-catalyzed pentafluorobenzylation. J Anal Toxicol, 23, 86-93.
70. Minami M, Hui D-M, Katsumata M et al. (1997). Method for the analysis of the methylphosphonic acid metabolites of sarin and its ethanol-substituted analogue in urine as applied to the victims of the Tokyo sarin disaster. J Chromatogr B, 695, 237-244.
71. Murachi T. (1963). A general reaction of diisopropyl phosphorofluoridate with proteins without direct effect on enzymic activities. Biochim Biophys Acta, 71, 239-241.
72. Nagao M, Takatori T, Matsuda Y et al. (1997). Definitive evidence for the acute sarin poisoning diagnosis in the Tokyo subway. Toxicol Appl Pharmacol, 144, 198-203.
73. Nakajima T, Sasaki K, Ozawa H et al. (1998). Urinary metabolites of sarin in a patient of the Matsumoto sarin incident. Arch Toxicol, 72, 601-603.
74. Niu T, Matijasevic Z, Austin-Ritchie P et al. (1996). A 32P-postlabeling method for the detection of adducts in the DNA of human fibroblasts exposed to sulfur mustard. Chem Biol Interact, 100, 77-84.
75. Noort D, Verheij ER, Hulst AG et al. (1996). Characterization of sulfur mustard induced structural modifications in human hemoglobin by liquid chromatography-tandem mass spectrometry. Chem Res Toxicol, 9, 781-787.
76. Noort D, Hulst AG, Platenburg DHJM et al. (1998). Quantitative analysis of O-isopropyl methylphosphonic acid in serum samples of Japanese citizens allegedly exposed to sarin: estimation of internal dosage. Arch Toxicol, 72, 671-675.
77. Noort D, Hulst AG, De Jong LPA et al. (1999). Alkylation of human serum albumin by sulfur mustard in vitro and in vivo: mass spectrometric analysis of a cysteine adduct as a sensitive biomarker of exposure. Chem Res Toxicol, 12, 715-721.
78. Noort D, Hulst AG, Fidder A et al. (2000). In vitro adduct formation of phosgene with albumin and hemoglobin in human blood. Chem Res Toxicol, 13, 719-726.
79. Noort D, Benschop HP and Black RM (2002a). Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol, 184, 116-126.
80. Noort D, Hulst AG and Jansen R (2002b). Covalent binding of nitrogen mustards to the cysteine-34 residue in human serum albumin. Arch Toxicol, 76, 83-88.
81. Noort D, Fidder A, Benschop HP et al. (2004a). Procedure for monitoring exposure to sulfur mustard based on modified Edman degradation of globin. J Anal Toxicol, 28, 311-315.
82. Noort D, Fidder A, Hulst AG et al. (2004b). Retrospective detection of exposure to sulfur mustard: improvements on an assay for liquid chromatography-tandem mass spectrometry analysis of albumin/sulfur mustard adducts. J Anal Toxicol, 28, 333-338.
83. Noort D and Black RM (2005). Methods for the retrospective detection of exposure to toxic scheduled chemicals. Part B: analysis of covalent adducts to proteins and DNA. In: ChemicalWeapons Convention Related Analysis (MMesilaakso, ed.), pp. 433-451. Chichester, UK: John Wiley & Sons Ltd.
84. Ohsawa I, Kanamori-Kataoka M, Tsuge K et al. (2004). Determination of thiodiglycol, a mustard gas hydrolysis product, by gas chromatography-mass spectrometry after tertbutyldimethylsilylation. J Chromatogr B, 1061, 235-241.
85. Olajos EJ and Salem H. (2001). Riot control agents: pharmacology, toxicology, biochemistry and chemistry. J Appl Toxicol, 21, 355-391.
86. Osborne MR, Wilman DE and Lawley PD. (1995). Alkylation of DNA by the nitrogen mustard bis (2-chloroethyl)methylamine. Chem Res Toxicol, 8, 316-320.
87. Peeples ES, Schopfer LM, Duysen EG et al. (2005). Albumin, a new biomarker of organophosphorus toxicant exposure, identified by mass spectrometry. Toxicol Sci, 83, 303-312.
88. Pohl LR, Branchflower RV, Highet RJ et al. (1981). The formation of diglutathionyl dithiocarbonate as a metabolite of chloroform, bromotrichloromethane and carbon tetrachloride. Drug Metab Disp, 9, 334-339.
89. Polhuijs M, Langenberg JP and Benschop HP. (1997). Newmethod for retrospective detection of exposure to organophosphorus anticholinesterases: application to alleged sarin victims of Japanese terrorists. Toxicol Appl Pharmacol, 146, 156-161.
90. Read RW and Black RM (2004a). Analysis of the sulfur mustard metabolite 1, 1'-sulfonylbis[2-S-(Nacetylcysteinyl) ethane] in urine by negative ion electrospray liquid chromatography-tandem mass spectrometry. J Anal Toxicol, 28, 352-356.
91. Read RW and Black RM (2004b). Analysis of β-lyase metabolites of sulfur mustard in urine by electrospray liquid chromatography-tandem mass spectrometry. J Anal Toxicol, 28, 346-351.
92. Reilly CA, Ehlhardt WJ, Jackson DA et al. (2003). Metabolism of capsaicin by cytochrome P450 produces novel dehydrogenated metabolites and decreases cytotoxicity to lung and liver cells. Chem Res Toxicol, 16, 336-349.
93. Reilly CA and Yost GS. (2005). Structural and enzymatic parameters that determine alkyl dehydrogenation/hydroxylation of capsaicinoids by cytochrome p450 enzymes. Drug Metab Dispos, 33, 530-536.
94. Riches J, Morton I, Read RW et al. (2005). The trace analysis of alkyl alkylphosphonic acids in urine using gas chromatography-ion trap negative ion tandem mass spectrometry. J Chromatogr B, 816, 251-258.
95. Riches J, Read RW and Black RM. (2007). Analysis of the sulphur mustard metabolite thiodiglycol in urine using isotope-dilution gas chromatographyion trap tandem mass spectrometry. J Chromatogr B, 845, 114-120.
96. Rietveld EC, Delbressine LPC, Waegemaekers THJM et al. (1983). 2-Chlorobenzylmercapturic acid, a metabolite of the riot control agent chlorobenzylidine malononitrile (CS) in the rat. Arch Toxicol, 54, 139-144.
97. Roberts JJ and Warwick GP. (1963). Studies of the mode of action of alkylating agents-VI. The metabolism of bis-2-chloroethylsulphide (mustard gas) and related compounds. Biochem Pharmacol, 12, 1329-1334.
98. Sandelowsky I, Simon GA, Bel P et al. (1992). N1-(2-Hydroxyethylthioethyl)-4-methylimidazole (4-met-1-imid-thiodiglycol) in plasma and urine: a novel metabolite following dermal exposure to sulphur mustard. Arch Toxicol, 66, 296-297.
99. Shih ML, Smith JR, McMonagle JD et al. (1991). Detection of metabolites of toxic alkyl methylphosphonates in biological samples. Biol Mass Spectrom, 20, 717-723.
100. Shih ML, McMonagle JD, Dolzine TW et al. (1994). Metabolite pharmacokinetics of soman, sarin and GF in rats and biological monitoring of exposure to toxic organophosphorus agents. J Appl Toxicol, 14, 195-199.
101. Sperry ML, Skanchy D and Marino MT. (1998). High-performance liquid chromatographic determination of N-[2-(hydroxyethyl)-N-(2-(7-guaninyl)ethyl]methylamine, a reaction product between nitrogen mustard and DNA and its application to biological samples. J Chromatogr B, 716, 187-193.
102. Stott WT, Waechter JM, Rick DL et al. (2000). Absorption, distribution, metabolism and excretion of intravenously and dermally administered triethanolamine in mice. Food Chem Toxicol, 38, 1043-1051.
103. Surh YJ, Ahn SH, Kim KCet al.. (1995). Metabolism of capsaicinoids: evidence for aliphatic hydroxylation and its pharmacological implications. Life Sci, 56, PL305-PL311.
104. Thulin H, Zorcec V, Segerback D et al. (1996). Oxazolidonylethyl adducts to hemoglobin and DNA following nornitrogen mustard exposure. Chem-Bio Interact, 99, 263-275.
105. Timchalk C, Poet TS, Kousba AA et al. (2004). Noninvasive biomonitoring approaches to determine dosimetry and risk following acute chemical exposure: analysis of lead or organophosphate insecticide in saliva. J Toxicol Environ Health Curr Issues, 67, 635-650.
106. Törnqvist M, Mowrer J, Jensen S et al. (1996). Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem, 154, 255-266.
107. Törnqvist M, Fred C, Haglund J et al. (2002). Protein adducts: quantitative and qualitative aspects of their formation, analysis and applications. J Chromatogr B, 778, 279-308.
108. Trams EG and Nadkarni MV. (1956). Studies on the N-dealkylation of nitrogen mustard and triethylenediamine by liver homogenates. Cancer Res, 16, 1069-1075.
109. Tsuchihashi H, Katagi M, Nishikawa M et al. (1998). Identification of metabolites of nerve agent VX in serum collected from a victim. J Anal Toxicol, 22, 383-388.
110. Tsuchihashi H, Katagi M, Tatsuno M et al. (2000). Determination of metabolites of nerve agent Oethyl-S-2-diisopropylaminoethyl methylphosphonothioate (VX). In: Natural and Selected Synthetic Toxins (Tu AT and Gaffield W, eds), ACS Symposium Series, 745, pp. 369-386. Washington, DC, USA: American Chemical Society.
111. United Nations (1986). Report of the mission dispatched by the Secretary-General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq, Report No. S/17911, 12 March. New York, NY, USA: United Nations.
112. Van der Schans GP, Scheffer AG, Mars-Groenendijk RH et al. (1994). Immunochemical detection of adducts of sulfur mustard to DNA of calf thymus and human white blood cells. Chem Res Toxicol, 7, 408-413.
113. Van der Schans GP, Noort D, Mars-Groenendijk RH et al. (2003). Immunochemical detection of sulfur mustard adducts with keratins in the stratum corneum of human skin. Chem Res Toxicol, 15, 21-25.
114. Van der Schans GP, Mars-Groenendijk R, De Jong LPA et al. (2004). Standard Operating Procedure for immunoslotblot assay for analysis of DNA/sulfur mustard adducts in human blood and skin. J Anal Toxicol, 28, 316-319.
115. Van der Schans MJ, Lander BJ, Van der Wiel H et al. (2003). Toxicokinetics of the nerve agent (+/-)-VX in anesthetized and atropinized hairless guinea pigs and marmosets after intravenous and percutaneous administration. Toxicol Appl Pharmacol, 191, 48-62.
116. Van der Schans MJ, Polhuijs M, Van Dijk C et al. (2004). Retrospective detection of exposure to nerve agents: analysis of phosphofluoridates originating from fluoride-induced reactivation of phosphylated BuChE. Arch Toxicol, 78, 508-524.
117. Van Welie RTH, van Dijck RGJM and Vermeulen NPE. (1992). Mercapturic acids, protein adducts and DNA adducts as biomarkers of electrophilic chemicals. Crit Rev Toxicol, 22, 271-306.
118. Wils ERJ, Hulst AG, de Jong ALet al. (1985). Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol, 9, 254-257.
119. Wils ERJ, Hulst AG and van Laar J. (1988). Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas, Part II. J Anal Toxicol, 12, 15-19.
120. Wooten JV, Ashley DL and Calafat AM (2002). Quantitation of 2-chlorovinylarsonous acid in human urine by automated solid-phase microextractiongas chromatography-mass spectrometry. J Chromatog B, 772, 147-153.
121. Worek F, Mast U, Kiderlen D et al. (1999). Improved determination of acetylcholinesterase activity in human blood. Clin Chim Acta, 288, 73-90.
122. World Health Organization (2004). Hydrogen cyanide and cyanides: human health aspects. Concise International Chemical Assessment Document 61. New York, NY, USA: World Health Organization, Geneva.
123. Young CL, Ash D, Driskell WJ et al. (2004). A rapid, sensitive method for the quantitation of specific metabolites of sulfur mustard using isotope-dilution gas chromatography-tandem mass spectrometry. J Anal Toxicol, 28, 339-345.